151 related articles for article (PubMed ID: 26788508)
61. Correlation of EGFR gene amplification with invasion and metastasis of non-small cell lung cancer.
Jia XF; Li J; Zhao HB; Liu J; Liu JJ
Genet Mol Res; 2015 Sep; 14(3):11006-12. PubMed ID: 26400330
[TBL] [Abstract][Full Text] [Related]
62. FGFR1 is an adverse outcome indicator for luminal A breast cancers.
Shi YJ; Tsang JY; Ni YB; Chan SK; Chan KF; Tse GM
Oncotarget; 2016 Jan; 7(4):5063-73. PubMed ID: 26673008
[TBL] [Abstract][Full Text] [Related]
63. Prognostic value of FGFR gene amplification in patients with different types of cancer: a systematic review and meta-analysis.
Chang J; Liu X; Wang S; Zhang Z; Wu Z; Zhang X; Li J
PLoS One; 2014; 9(8):e105524. PubMed ID: 25171497
[TBL] [Abstract][Full Text] [Related]
64. A new bright-field dual-colour chromogenic and silver in situ hybridization method for the detection of FGFR1 gene copy number status.
Boehm D; Vogel W; Franzen A; Schrock A; Bootz F; Heaseley LE; Braun M; Perner S
Virchows Arch; 2014 May; 464(5):547-51. PubMed ID: 24584974
[TBL] [Abstract][Full Text] [Related]
65. Fibroblast growth factor receptor 1 amplification in laryngeal squamous cell carcinoma.
Monico J; Miller B; Rezeanu L; May W; Sullivan DC
PLoS One; 2018; 13(1):e0186185. PubMed ID: 29351293
[TBL] [Abstract][Full Text] [Related]
66. Association of fibroblast growth factor receptor 1 gene amplification with poor survival in patients with esophageal squamous cell carcinoma.
Wang D; Du L; Wang Z; Liu X; Qin Y; Wang Q; Yang Z; Yao Z; Shi M; Shang B; Jia Y; Chen H; Qiao L; Wang X; Xiao Z; Liu Z
Oncotarget; 2017 Oct; 8(51):88857-88869. PubMed ID: 29179482
[TBL] [Abstract][Full Text] [Related]
67. MYCxing it up with FGFR1 in squamous cell lung cancer.
Lockwood W; Politi K
Cancer Discov; 2014 Feb; 4(2):152-4. PubMed ID: 24501305
[TBL] [Abstract][Full Text] [Related]
68. Pazopanib Sensitivity in a Patient With Breast Cancer and
Cheng FT; Ou-Yang F; Lapke N; Tung KC; Chen YK; Chou YY; Chen SJ
J Natl Compr Canc Netw; 2017 Dec; 15(12):1456-1459. PubMed ID: 29223982
[TBL] [Abstract][Full Text] [Related]
69. Genomics of squamous cell lung cancer.
Rooney M; Devarakonda S; Govindan R
Oncologist; 2013 Jun; 18(6):707-16. PubMed ID: 23728941
[TBL] [Abstract][Full Text] [Related]
70. FGFR1 expression defines clinically distinct subtypes in pancreatic cancer.
Haq F; Sung YN; Park I; Kayani MA; Yousuf F; Hong SM; Ahn SM
J Transl Med; 2018 Dec; 16(1):374. PubMed ID: 30593273
[TBL] [Abstract][Full Text] [Related]
71. FGFR1 amplifications in squamous cell carcinomas of the lung: diagnostic and therapeutic implications.
Schildhaus HU; Nogova L; Wolf J; Buettner R
Transl Lung Cancer Res; 2013 Apr; 2(2):92-100. PubMed ID: 25806220
[TBL] [Abstract][Full Text] [Related]
72. mRNA Expression of FGFR1 as Potential Marker for Predicting Prognosis of Surgical Resection of Small Cell Lung Cancer may be better than Protein Expression and Gene Amplification.
Qin J; Xie F; Wang F; Lu H
J Cancer; 2020; 11(16):4691-4699. PubMed ID: 32626515
[No Abstract] [Full Text] [Related]
73.
Chen S; Qiu Y; Guo P; Pu T; Feng Y; Bu H
Oncol Lett; 2018 Jun; 15(6):8206-8214. PubMed ID: 29805554
[TBL] [Abstract][Full Text] [Related]
74. [Multiple tracheal and bronchial glandular papilloma and adenocarcinoma with FGFR1-FILIP1 fusion and FGFR1 amplification: report of a case].
Yan LX; Liu CQ; Mei P; Liu C; Chen Y; Zhang MH; Liu J; Liu ZH; Zhang QL; Liu YH
Zhonghua Bing Li Xue Za Zhi; 2023 Aug; 52(8):847-849. PubMed ID: 37527993
[TBL] [Abstract][Full Text] [Related]
75. FGFR1 as a novel prognostic and predictive biomarker in squamous cell cancers of the lung and the head and neck area.
von Mässenhausen A; Franzen A; Heasley L; Perner S
Ann Transl Med; 2013 Oct; 1(3):23. PubMed ID: 25332967
[TBL] [Abstract][Full Text] [Related]
76. The clinical pathological characteristics and prognosis of FGFR1 gene amplification in non-small-cell lung cancer: a meta-analysis.
Xie FJ; Lu HY; Zheng QQ; Qin J; Gao Y; Zhang YP; Hu X; Mao WM
Onco Targets Ther; 2016; 9():171-81. PubMed ID: 26793001
[TBL] [Abstract][Full Text] [Related]
77. Epithelioid inflammatory myofibroblastic sarcoma treated with ALK inhibitor: a case report and review of literature.
Liu Q; Kan Y; Zhao Y; He H; Kong L
Int J Clin Exp Pathol; 2015; 8(11):15328-32. PubMed ID: 26823889
[TBL] [Abstract][Full Text] [Related]
78. p38 Mediates Resistance to FGFR Inhibition in Non-Small Cell Lung Cancer.
Zarczynska I; Gorska-Arcisz M; Cortez AJ; Kujawa KA; Wilk AM; Skladanowski AC; Stanczak A; Skupinska M; Wieczorek M; Lisowska KM; Sadej R; Kitowska K
Cells; 2021 Nov; 10(12):. PubMed ID: 34943871
[TBL] [Abstract][Full Text] [Related]
79. Fibroblast growth factor receptor 1 gene amplification and protein expression in human lung cancer.
Elakad O; Lois AM; Schmitz K; Yao S; Hugo S; Lukat L; Hinterthaner M; Danner BC; von Hammerstein-Equord A; Reuter-Jessen K; Schildhaus HU; Ströbel P; Bohnenberger H
Cancer Med; 2020 May; 9(10):3574-3583. PubMed ID: 32207251
[TBL] [Abstract][Full Text] [Related]
80. The association between fibroblast growth factor receptor 1 gene amplification and lung cancer: a meta-analysis.
Miao JL; Zhou JH; Cai JJ; Liu RJ
Arch Med Sci; 2020; 16(1):16-26. PubMed ID: 32051701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
